Nested case-control study of the emergence of tigecycline resistance in multidrug-resistant Klebsiella pneumoniae

Antimicrobial Agents and Chemotherapy

Volumn 57, Issue 11, 2013, Pages 5743-5746

  Nigo, Masayuki ^a   Cevallos, Catalina Salinas ^a   Woods, Krystina ^a   Flores, Vicente Maco ^a,b   Francis, Gweneth ^a,c   Perlman, David C ^a   Revuelta, Manuel ^a   Mildvan, Donna ^a   Waldron, Mary ^a   Gomez, Tessa ^a   Koshy, Sanjana ^a   Jodlowski, Tomasz ^a   Riley, William ^a   Ruhe, Jörg J ^a  

^a BETH ISRAEL MEDICAL CENTER   (United States)

^b INSTITUTO DE MEDICINA TROPICAL ALEXANDER VON HUMBOLDT   (Peru)

^c MedEx   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; AZTREONAM; CARBAPENEM; CEPHALOSPORIN; CLINDAMYCIN; LINEZOLID; METRONIDAZOLE; POLYMYXIN; QUINOLONE DERIVATIVE; TIGECYCLINE; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM ISOLATE; CASE CONTROL STUDY; CHARLSON COMORBIDITY INDEX; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EXPOSURE; DRUG TREATMENT FAILURE; FEMALE; FOLLOW UP; HUMAN; KLEBSIELLA PNEUMONIAE; MALE; MOLECULAR TYPING; MONOTHERAPY; MULTIDRUG RESISTANT KLEBSIELLA PNEUMONIAE; PRIORITY JOURNAL; URINARY TRACT INFECTION;

AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CASE-CONTROL STUDIES; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; LOGISTIC MODELS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MINOCYCLINE; TIME FACTORS;

EID: 84885926558     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00827-13     Document Type: Article

References (18)

1. Gupta N, Limbago BM, Patel JB, Kallen AJ. 2011. Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention. Clin. Infect. Dis. 53: 60-67.
2. Nordmann P, Cuzon G, Naas T. 2009. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect. Dis. 9:228-236.
3. Sader HS, Flamm RK, Jones RN. 2013. Tigecycline activity tested against antimicrobial resistant surveillance subsets of clinical bacteria collected worldwide (2011). Diagn. Microbiol. Infect. Dis. 76:61-68.
4. Kelesidis T, Karageorgopoulos DE, Kelesidis I, Falagas ME. 2008. Tigecycline for the treatment of multidrug-resistant Enterobacteriaceae: a systematic review of the evidence from microbiological and clinical studies. J. Antimicrob. Chemother. 62:895-904.
5. Arya SC, Agarwal N. 2010. Emergence of tigecycline resistance amongst multi-drug resistant gram negative isolates in a multi-disciplinary hospital. J. Infect. 61:358-359.
6. Neonakis IK, Stylianou K, Daphnis E, Maraki S. 2011. First case of resistance to tigecycline by Klebsiella pneumoniae in a European University Hospital. Indian J. Med. Microbiol. 29:78-79.
7. Spanu T, De Angelis G, Cipriani M, Pedruzzi B, D'Inzeo T, Cataldo MA, Sganga G, Tacconelli E. 2012. In vivo emergence of tigecycline resistance in multidrug-resistant Klebsiella pneumoniae and Escherichia coli. Antimicrob. Agents Chemother. 56:4516-4518.
8. Al-Qadheeb NS, Althawadi S, Alkhalaf A, Hosaini S, Alrajhi AA. 2010. Evolution of tigecycline resistance in Klebsiella pneumoniae in a single patient. Ann. Saudi Med. 30:404-407.
9. Rodríguez-Avial C, Rodríguez-Avial I, Merino P, Picazo JJ. 2012. Klebsiella pneumoniae: development of a mixed population of carbapenem and tigecycline resistance during antimicrobial therapy in a kidney transplant patient. Clin. Microbiol. Infect. 18:61-66.
10. Tsai HY, Liao CH, Cheng A, Liu CY, Huang YT, Sheng WH, Hsueh PR. 2012. Emergence of tigecycline-resistant Klebsiella pneumoniae after tigecycline therapy for complicated urinary tract infection caused by carbapenem-resistant Escherichia coli. J. Infect. 65:584-586.
11. Clinical and Laboratory Standards Institute. 2006. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: approved standard M7-A7, 7th ed. Clinical and Laboratory Standards Institute, Wayne, PA.
12. Anderson KF, Lonsway DR, Rasheed JK, Biddle J, Jensen B, McDougal LK, Carey RB, Thompson A, Stocker S, Limbago B, Patel JB. 2007. Evaluation of methods to identify the Klebsiella pneumoniae carbapenemase in Enterobacteriaceae. J. Clin. Microbiol. 45:2723-2725.
13. Charlson ME, Pompei P, Ales KL, MacKenzie CR. 1987. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J. Chronic Dis. 40:373-383.
14. Tumbarello M, Viale P, Viscoli C, Trecarichi EM, Tumietto F, Marchese A, Spanu T, Ambretti S, Ginocchio F, Cristini F, Losito AR, Tedeschi S, Cauda R, Bassetti M. 2012. Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemaseproducing K. pneumoniae: importance of combination therapy. Clin. Infect. Dis. 55:943-950.
15. Cho SY, Kang CI, Chung DR, Peck KR, Song JH, Jang JH. 2012. Breakthrough bacteremia due to extended-spectrum-β-lactamaseproducing Klebsiella pneumoniae during combination therapy with colistin and tigecycline. Antimicrob. Agents Chemother. 56:4994 -4995.
16. Satlin MJ, Kubin CJ, Blumenthal JS, Cohen AB, Furuya EY, Wilson SJ, Jenkins SG, Calfee DP. 2011. Comparative effectiveness of aminoglycosides, polymyxin B, and tigecycline for clearance of carbapenem-resistant Klebsiella pneumoniae from urine. Antimicrob. Agents Chemother. 55:5893-5899.
17. Veleba M, Schneiders T. 2012. Tigecycline resistance can occur independently of the ramA gene in Klebsiella pneumoniae. Antimicrob. Agents Chemother. 56:4466-4467.
18. Nigo M, Cevallos CS, Woods K, Flores VM, Francis G, Mildvan D, Waldron M, Gomez T, Koshy S, Ruhe J. 2012. Rates of and risk factors for the emergence of tigecycline resistance among multidrug-resistant Klebsiella pneumoniae isolates, abstr P1875. 22nd Eur. Congr. Clin. Microbiol. Infect. Dis.